Washington,
D.C. 20549
FORM
6-K
REPORT
OF
FOREIGN ISSUER
Pursuant
to Rule 13a-16 or 15d-16 of
the
Securities Exchange Act of 1934
For
the month of November 2005
Commission
File Number 000-51122
pSivida
Limited
(Translation
of registrant’s name into English)
Level
12
BGC Centre
28
The
Esplanade
Perth
WA
6000
(Address
of principal executive offices)
(Indicate
by check mark whether the registrant files or will file annual reports under
cover Form 20-F or Form 40-F).
Form
20-F
ý Form
40-F o
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(1):
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted
by Regulation S-T Rule 101(b)(7):
Indicate
by check mark whether the registrant by furnishing the information contained
in
this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes
o No
ý
If
"Yes"
is marked, indicate below the file number assigned to the registrant in
connection with Rule 12g3-2(b): 82- ___.
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant,
pSivida Limited, has duly caused this report to be signed on its behalf by
the
undersigned, thereunto duly authorized.
| pSivida Limited | ||
| |
|
|
| Date: November 18, 2005 | By: | /s/ Aaron Finlay |
|
Aaron Finlay |
||
| Chief Financial Officer and Company Secretary | ||
EXHIBIT
INDEX
|
EXHIBIT
99.1:
|
Appendix
3Z Final Directors Interest Notice
|
2
Exhibit
99.1
Appendix
3Z
Final
Director’s Interest Notice
Rule
3.19A.3
Appendix
3Z
Final
Director’s Interest Notice
Information
or documents not available now must be given to ASX as soon as available.
Information and documents given to ASX become ASX’s property and may be made
public.
Introduced
30/9/2001.
|
Name
of entity pSivida
Limited
|
|
ABN 78
009 232 026
|
We
(the
entity) give ASX the following information under listing rule 3.19A.3 and
as
agent for the director for the purposes of section 205G of the Corporations
Act.
|
Name
of director
|
Dr
Roger Aston
|
|
Date
of last notice
|
22
November 2004
|
|
Date
that director ceased to be director
|
16
November 2005
|
Part
1 - Director’s relevant interests in securities of which the director is the
registered holder
In
the case of a trust, this includes interests in the trust made available
by the
responsible entity of the trust
|
Number
& class of securities
5,618,586 Ordinary
Fully Paid Shares escrowed for a period of 6 months from the completion
of
the CDS acquisition.
500,000
Unlisted
options for ordinary shares @ 61 cents expiring 31 December
2007
549,111
Unlisted options for ordinary shares @ 118 cent expiring 5 August,
2009
|
Part
2 - Director’s relevant interests in securities of which the director is not the
registered holder
In
the case of a trust, this includes interests in the trust made available
by the
responsible entity of the trust
|
Name
of holder & nature of interest
Note:
Provide details of the circumstances giving rise to the relevant
interest
Equity
(Trust) Jersey Ltd
(Beneficial
Owner)
Newtonmore
Biosciences Pty Ltd
|
Number
& class of securities
1,475,000 Ordinary
Full Paid Shares escrowed for a period of 6 months from the completion
of
the CDS acquisition.
500,000 Unlisted
options
for ordinary shares @ 118 cent expiring 5 August, 2009
|
+
See
chapter 19 for defined terms.
Appendix
3Z Page 1
Appendix
3Z
Final
Director’s Interest Notice
Part
3 - Director’s interests in contracts
|
Detail
of contract
|
A
6
month consultancy contract for a fee of $125,000.
|
|
Nature
of interest
|
Provision
of consulting services.
|
|
Name
of registered holder
(if
issued securities)
|
|
|
No.
and class of securities to which interest relates
|
+
See
chapter 19 for defined terms.
Appendix
3Z Page 2